Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial
Annals of the Rheumatic Diseases · 2026-07 · 85 (7) · 1255-1267
DOI: 10.1016/j.ard.2026.03.025 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of the Rheumatic Diseases, 2026-07. Verfasst von Esperanza Naredo und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain; Joint and Bone Research Unit, IIS-Fundacion Jimenez Diaz-UAM, …. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Etanercept, Methotrexate, Antirheumatic Agents. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Agencia Española de Medicamentos y Productos Sanitarios, Eli Lilly and Company, Instituto de Salud Carlos III.
Abstract (Originalsprache)
OBJECTIVES The primary objective of this randomised, active-controlled, international, multicentre, phase IV clinical trial was to demonstrate noninferiority of the response of ultrasound-assessed synovitis to baricitinib treatment, alone and in combination with methotrexate (MTX), compared with etanercept with MTX in rheumatoid arthritis (RA). METHODS Adult patients with active RA and inadequate response to MTX were randomised into 3 parallel treatment groups: baricitinib monotherapy, baricitinib plus MTX, and etanercept plus MTX. The patients underwent clinical, ultrasound, and laboratory assessments at baseline, 4, 12, and 24 weeks. Ultrasound synovitis was scored 0 to 3 in B-mode, Doppler mode, and a combination of both modes. The primary endpoint was the change in the Global European Alliance of Associations for Rheumatology-Outcome Measures in Rheumatology Synovitis Score (GLOESS) for bilateral wrist and metacarpophalangeal joints at week 12. Noninferiority was stated if the changes in the baricitinib groups were above the lower limit of the noninferiority range, defined as 80% of changes observed in the etanercept plus MTX group. Changes in serum concentrations of different mediators were analysed at 24 weeks. RESULTS One hundred fifty patients (109 women and 41 men) were randomised. All clinical and ultrasound variables showed significant improvement starting from week 4 across the 3 treatment arms (P < .050). Noninferiority of baricitinib (monotherapy and plus MTX) was confirmed against etanercept with MTX for GLOESS at week 12 (P < .050). Changes in metalloprotease-3 concentration significantly correlated with changes in all ultrasound scores. CONCLUSIONS The response of ultrasound-assessed synovitis to baricitinib, alone or in combination with MTX, was noninferior to that of etanercept with MTX.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain; Joint and Bone Research Unit, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain; Faculty of Medicine, Department of Medicine, Autonomous…
- Department of Rheumatology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain; Faculty of Medicine, Department of Medicine, Autonomous University of Madrid, Madrid, Spain.
- Department of Rheumatology, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal; Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
- Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain; Department of Rheumatology, Blua Sanitas Valdebebas Hospital, Madrid, Spain; Department of Medicine, Faculty of Medicine, Health, and Sports,…
- Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain.
- Department of Rheumatology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Förderung
- Agencia Española de Medicamentos y Productos Sanitarios
- Eli Lilly and Company
- Instituto de Salud Carlos III
- Sher-e-Bangla Agricultural University
- Universidad Autónoma de Madrid
Zitieren
APA
Naredo, E., Olivas-Vergara, O., Borges, P. E., Recuero-Díaz, S., Saraiva, F., Martins-Martinho, J., Costa, F., Tenazinha, C., Duarte-Monteiro, A. M., Melo, A. T., Guillén-Astete, C. A., Rodríguez-García, A., Blanco-Cáceres, B., Boteanu, A. L., Mera-Varela, A., Pérez-Pampín, E., Golán, Y. L., Campos Fernández, C., Fragío Gíl, J. J., …, & Largo, R. (2026). Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial. Annals of the Rheumatic Diseases, 85(7), 1255-1267. https://doi.org/10.1016/j.ard.2026.03.025
Vancouver
Naredo E, Olivas-Vergara O, Borges PE, Recuero-Díaz S, Saraiva F, Martins-Martinho J, et al. Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial. Annals of the Rheumatic Diseases. 2026;85(7):1255-1267. doi:10.1016/j.ard.2026.03.025
BibTeX
@article{Naredo2026,
author = {Naredo, Esperanza and Olivas-Vergara, Otto and Borges, Pablo E and Recuero-Díaz, Sheila and Saraiva, Fernando and Martins-Martinho, Joana and Costa, Filipa and Tenazinha, Catarina and Duarte-Monteiro, Ana Margarida and Melo, Ana Teresa and Guillén-Astete, Carlos A and Rodríguez-García, Ana and Blanco-Cáceres, Boris and Boteanu, Alina L and Mera-Varela, Antonio and Pérez-Pampín, Eva and Golán, Yolanda López and Campos Fernández, Cristina and Fragío Gíl, Jorge Juan and González Mazario, Roxana and Steiner, Martina and Vergara-Dangond, Cristina and Paredes-Romero, María Beatriz and Muñoz-Fernández, Santiago and Stoenoiu, Maria Simona and Toukap, Adrien Nzeusseu and Durnez, Anne and de Agustín de Oro, Juan José and Añez, Gustavo A and Coronel, Luis and Vicente-Rabaneda, Esther F and Castañeda, Santos and Llorente, Irene and Padovano, Ilaria and Gouze, Hélène and Leboime, Ariane and Breban, Maxime and Uson, Jaqueline and Villaverde-García, Virginia and Miguélez-Sánchez, Juan Roberto and Pérez García, Carolina and Meraz-Ostiz, Juan Antonio and Polino, Luciano and Finzel, Stephanie and Kanne, Anna-Maria and Jandova, Ilona and Mediero, Aránzazu and Herencia, Carmen and Herrero-Beaumont, Gabriel and Largo, Raquel},
title = {Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {7},
pages = {1255--1267},
doi = {10.1016/j.ard.2026.03.025}
}
EUVIMED